Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of ARS 423.81 trillion. The enterprise value is 459.24 trillion.
| Market Cap | 423.81T |
| Enterprise Value | 459.24T |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Mar 12, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.93% |
| Shares Change (QoQ) | -0.57% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 37.30% |
| Float | 1.82B |
Valuation Ratios
The trailing PE ratio is 20.88 and the forward PE ratio is 17.58.
| PE Ratio | 20.88 |
| Forward PE | 17.58 |
| PS Ratio | 5.15 |
| PB Ratio | 6.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.59 |
| P/OCF Ratio | 15.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.29, with an EV/FCF ratio of 17.98.
| EV / Earnings | 22.63 |
| EV / Sales | 5.57 |
| EV / EBITDA | 13.29 |
| EV / EBIT | 16.61 |
| EV / FCF | 17.98 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.12 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 2.02 |
| Interest Coverage | 16.61 |
Financial Efficiency
Return on equity (ROE) is 30.81% and return on invested capital (ROIC) is 23.60%.
| Return on Equity (ROE) | 30.81% |
| Return on Assets (ROA) | 11.14% |
| Return on Invested Capital (ROIC) | 23.60% |
| Return on Capital Employed (ROCE) | 22.71% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.09B |
| Profits Per Employee | 269.66M |
| Employee Count | 75,883 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, Novartis AG has paid 3.46 trillion in taxes.
| Income Tax | 3.46T |
| Effective Tax Rate | 14.59% |
Stock Price Statistics
The stock price has increased by +82.03% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +82.03% |
| 50-Day Moving Average | 53,566.20 |
| 200-Day Moving Average | 43,944.85 |
| Relative Strength Index (RSI) | 67.45 |
| Average Volume (20 Days) | 148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of ARS 82.26 trillion and earned 20.30 trillion in profits. Earnings per share was 10,377.51.
| Revenue | 82.26T |
| Gross Profit | 62.49T |
| Operating Income | 27.58T |
| Pretax Income | 23.73T |
| Net Income | 20.30T |
| EBITDA | 34.07T |
| EBIT | 27.58T |
| Earnings Per Share (EPS) | 10,377.51 |
Balance Sheet
The company has 16.74 trillion in cash and 51.46 trillion in debt, with a net cash position of -34,723.29 billion.
| Cash & Cash Equivalents | 16.74T |
| Total Debt | 51.46T |
| Net Cash | -34,723.29B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 67.56T |
| Book Value Per Share | 35,087.92 |
| Working Capital | 4.62T |
Cash Flow
In the last 12 months, operating cash flow was 27.79 trillion and capital expenditures -2,246.77 billion, giving a free cash flow of 25.54 trillion.
| Operating Cash Flow | 27.79T |
| Capital Expenditures | -2,246.77B |
| Free Cash Flow | 25.54T |
| FCF Per Share | n/a |
Margins
Gross margin is 75.97%, with operating and profit margins of 33.53% and 24.67%.
| Gross Margin | 75.97% |
| Operating Margin | 33.53% |
| Pretax Margin | 28.85% |
| Profit Margin | 24.67% |
| EBITDA Margin | 41.42% |
| EBIT Margin | 33.53% |
| FCF Margin | 31.05% |
Dividends & Yields
This stock pays an annual dividend of 624.65, which amounts to a dividend yield of 1.07%.
| Dividend Per Share | 624.65 |
| Dividend Yield | 1.07% |
| Dividend Growth (YoY) | 34.57% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 55.91% |
| Buyback Yield | 3.93% |
| Shareholder Yield | 5.00% |
| Earnings Yield | 4.79% |
| FCF Yield | 6.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Oct 22, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novartis AG has an Altman Z-Score of 3.81 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.81 |
| Piotroski F-Score | 7 |